IntelliCyt Corp collects $7.4 mln

By Iris Dorbian — 4 months ago

Albuquerque, New Mexico-based IntelliCyt Corp, a provider of integrated platforms to accelerate drug discovery, antibody discovery and immunology, has closed $7.4 million in new financing, which includes $5.4 million in venture financing and a $2 million debt facility. Arboretum Ventures led the venture funding round with participation from current backers Prolog Ventures, Verge Fund and New Mexico Community Capital. Oxford Finance provided the debt funding.

Continue

Green Cross and POSCO Capital leads $13.5 mln round for Juventas Therapeutics

By Iris Dorbian — 9 months ago

Cleveland-based Juventas Therapeutics, a biotech company that is developing non-viral gene therapies that treat advanced cardiovascular diseases, has raised $13.5 million in Series B-2 funding. Green Cross Holdings and POSCO Capital led the round. Also, Juventas has received $6 million in debt funding from Oxford Finance and may get $9 million more “if specific milestones are met.” In addition to the financing, Juventas has named James Boland, Ernst & Young‘s retired vice chairman, to its board of directors. Boland is also former president and CEO of the Cleveland Cavaliers.

Continue

Oxford Finance, Square 1 provide $10 mln to Tarsa Therapeutics

By Chris Witkowsky — 1 year ago

Oxford Finance and Square 1 Bank have provided a $10 million senior credit facility to biopharmaceutical company Tarsa Therapeutics. The company plans to use the proceeds to help file a drug application with the U.S. Food and Drug Administration for medication to treat post-menopausal osteoporosis, targeted for early 2015. Tarsa also announced biopharmaceutical veteran Daniel Soland has joined the company’s board.

Continue

IntelliCyt grabs $4 mln from Oxford Finance

By Iris Dorbian — 2 years ago

Specialty finance firm Oxford Finance has provided a $4 million debt facility to IntelliCyt Corp. The loan will be used for working capital, marketing and product development. Headquartered in Albuquerque, New Mexico, IntelliCyt develops high-throughput cell and bead-based screening solutions.

Continue

Sonendo snags $10 mln from Oxford Finance

By Iris Dorbian — 2 years ago

Sonendo said Monday that it has received $10 million in debt financing from Oxford Finance. Based in Laguna Hills, Calif., Sonendo is a provider of technologies for endodontic therapy. Its backers include OrbiMed Advisors, Themes Investment Partners, Fjord Ventures and NeoMed Management.

Continue

Molecular Diagnostics Co XDx Secures Debt Financing

By Angela Sormani — 3 years ago

Oxford Finance has announced a $15 million round of debt financing for XDx. Silicon Valley Bank acted as co-lender in this transaction. XDx is based in Brisbane, California and is a molecular diagnostics company. Proceeds of the loan will be used for working capital and to fund the development of new diagnostic applications.

Continue

Vitae Secures Debt Financing

By Angela Sormani — 4 years ago

Vitae Pharmaceuticals has secured a $15 million round of debt financing from Oxford Finance, a specialty finance firm that provides senior debt to life sciences and healthcare services companies and Silicon Valley Bank. The funds will be used to support the progress of Vitae’s drug pipeline, which includes treatments for chronic kidney disease, diabetes, Alzheimer’s […]

Continue

Radius Health Closes $91M Round

5 years ago

Radius Health Inc. said Tuesday that it closed a $91 million third round of financing. The round includes $66 million in equity financing, and a commitment by GE Capital, Healthcare Financial Services and Oxford Finance for a $25 million multi-draw term loan facility. Five new investors–including BB Biotech AG, Brookside Capital, Saints Capital, Nordic Bioscience, and Ipsen Pharma SAS–joined existing investors MPM Capital, BB Biotech Ventures, MPM Bio IV NVS Strategic Fund, The Wellcome Trust, HealthCare Ventures, and Scottish Widows Investment Partnership in the equity portion of the round. Radius Health is based in Cambridge, Mass. Radius also announced that immediately following the initial closing of the financing, it merged with MPM Acquisition Corp., an unlisted public reporting shell company. The combined company will go by the name Radius Health. Radius is a developer of drug therapies for osteoporosis and women’s health.

Continue

Oxford Finance Nets $460M

5 years ago

Oxford Finance, a company that makes loans to life science and healthcare companies, has raised $460 million from Sumitomo Corp. and private equity firm Welsh, Carson, Anderson & Stowe, Reuters reported. Oxford Finance has been majority-owned by Sumitomo since 2004. The company will use the new money, in part, to expand its portfolio.

Continue